Tandem Labs Overview

  • Year Founded
  • 1981

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 150


  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Tandem Labs General Information


Provider of services as a contract research organization (CRO), serving the pharmaceutical, biopharmaceutical, and biotechnology industries. The company develops, validates, and performs spectrometry-based methods in support of clinical, pre-clinical, and discovery studies in a stringent GLP environment. It offers GLP bioanalytical services, such as method development and validation, dose formulation analysis, pre-clinical and clinical sample analysis, TK/PK analysis and reporting, and protein-binding studies; as well as rapid turnaround non-GLP discovery services, including protein-binding assays, and discovery bioanalysis. It also provides GLP immunoanalytical services, which include biomarker assay development, validation, and sample analysis; ligand-binding, immunogenicity, and cell-based assays; biotherapeutic macromolecule PK; and electrochemiluminescence, quantitative immunoassays, and multiplexed assays. It has supported nearly 100 pharmaceutical, biopharmaceutical, and biotechnical clients.

Contact Information

Formerly Known As
Northwest Toxicology, Northwest Bioanalytical, Northwest Toxicology Consultants, Northwest Analytical Consulting Laboratories
Ownership Status
Financing Status
Formerly PE-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Drug Discovery
Primary Office
  • 1121 East 3900 South
  • Suite 105
  • Millcreek, UT 84124
  • United States
+1 (801) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tandem Labs Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tandem Labs‘s full profile, request access.

Request a free trial

Tandem Labs Executive Team (7)

Name Title Board Seat Contact Info
Paul Sakata Manager
You’re viewing 1 of 7 executive team members. Get the full list »

Tandem Labs Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tandem Labs Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tandem Labs‘s full profile, request access.

Request a free trial

Tandem Labs Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PharmaKD 13-Sep-2006 0000000000 Other Healthcare Technology Systems 00000 000
To view Tandem Labs’s complete investments history, request access »